Stem Cell Cartilage Regeneration Market Analysis-2027

SEATTLE - Jan. 21, 2021 - PRLog -- Global Stem Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), by Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), by End User (Hospitals & Clinics and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 298.3 million in 2019, and is expected to exhibit a CAGR of 9.1% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights

Stem cell-based therapy is a key focus in functional replacement of cartilage regeneration. Rising incidence of osteoarthritis among the global population is expected to increase adoption of efficient and promising treatment such as stem cell therapy during the forecast period. There were 14 million individuals in the U.S. who has symptomatic knee osteoarthritis and nearly 2 million people under the age of 45 that were suffering from symptomatic knee osteoarthritis as per Arthritis Foundation, 2017.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2448

Furthermore, companies are also focusing on research and development activities, in order to launch novel products to increase their revenue in the stem cell cartilage regeneration market. According to Alliance for Regenerative Medicine, globally there were 946 clinical trials in progress in 2017, an 18% increase over the previous year.

Browse 32 Market Data Tables and 24 Figures spread through 154 Pages and in-depth TOC on "Global Stem Cell Cartilage Regeneration Market"

Rising mergers and acquisitions by major players to strengthen their share in this market is further expected to drive growth of stem cell cartilage regeneration market.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/stem-cell-cartilage-regeneration-market-2448

Key Takeaways of the Global Stem Cell Cartilage Regeneration Market:

The global stem cell cartilage regeneration market is expected to exhibit a CAGR of 9.1% over the forecast period (2019-2027), owing growing number of knee cartilage defects in patients with osteoarthritis (OA)

Among stem cell type, mesenchymal segment is expected to hold dominant position in the global stem cell cartilage regeneration market, owing to growing research and development activities pertaining to mesenchymal stem cells by various research organizations.

Major players operating in the global stem cell cartilage regeneration market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2448